Stock Events

Hyundai Bioscience. 

₩17,800
0
+₩70+0.39% Friday 06:30

Statistics

Day High
17,940
Day Low
17,700
52W High
41,200
52W Low
17,100
Volume
120,623
Avg. Volume
273,527
Mkt Cap
703.99B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

13MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
84.72
85.06
85.39
85.72
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 048410.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.
Show more...
CEO
Jong-Won Choi
Country
KR
ISIN
KR7048410005

Listings